Effect of angiotensin converting enzyme gene I/D polymorphism in patients with metabolic syndrome in North Indian population

Chinese Medical Journal

Volumn 124, Issue 1, 2011, Pages 45-48

  Mittal, Gaurav ^a   Gupta, Vibhanshu ^a   Haque, Shahzad F ^a   Khan, Anwer S ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

ACE gene polymorphism; Metabolic syndrome; North Indian

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UREA;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DNA DETERMINATION; FEMALE; GENE DELETION; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; INDIA; MALE; METABOLIC SYNDROME X; OBESITY; POLYMERASE CHAIN REACTION; SYSTOLIC BLOOD PRESSURE; TERTIARY HEALTH CARE; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 78651254782     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.01.009     Document Type: Article

References (22)

1. Groop L. Genetics of the metabolic syndrome. Br J Nutr 2000; 83 Suppl 1: S39-S84.
2. Mykkanen L, Kuusisto J, Pyorala K, Laakso M. Cardiovascular disease risk factors as predictors of type 2 (noninsulin-dependent) diabetes mellitus in elderly subjects. Diabetologia 1993; 36: 553-559.
3. Nicholls MG, Richards AM, Agarwal M. The importance of the renin-angiotensin system in cardiovascular disease. J Hum Hypertens. 1998; 12: 295-299.
4. Cassis LA, Police SB, Yiannikouris F, Thatcher SE. Local adipose tissue renin-angiotensin system. Cur Hypertens Rep 2008; 10: 93-98.
5. Hsieh MC, Lin SR, Hsieh TJ, Hsu CH, Chen HC, Shin SJ, et al. Increased frequency of angiotensin-converting enzyme D/D genotype in patients with type 2 diabetes in Taiwan. Nephro Dial Transplant 2001; 5: 1008-1013.
6. Katsuya T, Horiuchi M, Chen YD, Koike G, Pratt RE, Dzau VJ, et al. Relations between deletion polymorphism of the angiotensin-converting enzyme gene and insulin resistance, glucose intolerance, hyperinsulinemia, and dyslipidemia. Arterioscler Thromb Vasc Biol 1995; 15: 779-782.
7. Mastana S, Nunn J. Angiotensin-converting enzyme deletion polymorphism is associated with hypertension in a Sikh population. Hum Hered 1997; 47: 250-253.
8. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-644.
9. Staessen JA, Wang JG, Ginocchio G, Petrov V, Saavedra AP, Soubrier F, et al. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular- renal risk. J Hypertens 1997; 15: 1579-1592.
10. O'Donnell CJ, Larson MG, Lindpainter K, Rao VS, Ordovas JM, Schaefer EJ, et al. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham heart study. Circulation 1998; 97: 766-772
11. Lee YJ, Tsai JCR. ACE gene insertion/deletion polymorphism associated with 1998. World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients. Diabetes Care 2002; 25: 1002-1008.
12. Bengtsson K, Orho-Melander M, Lindblad U, Melander O, Bøg-Hansen E, Ranstam J, et al. Polymorphism in the angiotensin converting enzyme but not in the angiotensinogen gene is associated with hypertension and type 2 diabetes: the Skaraborg Hypertension and diabetes project. J Hypertens 1999; 17: 1569-1575.
13. Viswanathan V, Zhu Y, Bala K, Dunn S, Snehalatha C, Ramachandran A, et al. Association between ACE gene polymorphism and diabetic nephrophathy in South Indian patients. J Pancreas 2001; 2: 83-87.
14. Bonnet F, Patel S, Laville M, Balkau B, Favuzzi A, Monti LD, et al. Influence of the ACE gene insertion/deletion polymer-phism on insulin sensitivity and impaired glucose tolerance in healthy subjects. Diabetes Care 2008; 31: 789-794.
15. Zhang B, Tanaka H, Shono N, Miura S, Kiyonaga A, Shindo M, et al. The I allele of the angiotensin-converting enzyme gene is associated with an increased percentage of slow-twitch type I fibers in human skeletal muscle. Clin Genet 2003; 63: 139-144.
16. Strazzullo P, Iacone R, Iacoviello L, Russo O, Barba G, Russo P, et al. Genetic variation in the renin-angiotensin system and abdominal adiposity in men: the Olivetti Prospective Heart Study. Ann Intern Med 2003; 138: 17-23.
17. Cooper R, McFarlane-Anderson N, Bennett FI, Wilks R, Puras A, Tewksbury D, et al. ACE, angiotensinogen and obesity: a potential pathway leading to hypertension. J Hum Hypertens 1997; 11: 107-111.
18. Umemura S, Nyui N, Tamura K, Hibi K, Yamaguchi S, Nakamaru M, et al. Plasma angiotensinogen concentrations in obese patients. Am J Hypertens 1997; 10: 629-633.
19. Nagi DK, Foy CA, Mohamed-Ali V, Yudkin JS, Grant PJ, Knowler WC. Angiotensin-1-converting enzyme (ACE) gene polymorphism, plasma ACE levels, and their association with the metabolic syndrome and electrocardiographic coronary artery disease in Pima Indian. Metabolism 1998; 47: 622-626.
20. Cardoso RL, Nogueira AR, Salis LH, Urményi TP, Silva R, Moura-Neto RS, et al. The association of ACE gene D/I polymorphism with cardiovascular risk factors in a population from Rio de Janeiro. Braz J Med Biol Res 2008; 41: 512-518.
21. Huang XH, Rantalaiho V, Wirta O, Pasternack A, Koivula T, Hiltunen T, et al. Relationship of the angiotensin-converting enzyme gene polymorphism to glucose intolerance, insulin resistance, and hypertension in NIDDM. Hum Genet 1998; 102: 372-378.
22. Abdolrahim N, Nakhjavani M, Golmohamadi T, Dibai L. Association of angiotensin-converting enzyme gene insertion/ deletion polymorphism with metabolic syndrome in Iranians with type 2 diabetes mellitus. Arch Iranian Med 2008; 11: 3-9.